NRNP 6675 MIDTERM EXAM (YEAR 2026 – 100/100 POINTS)
LATEST UPDATE|| NRNP 6675 MIDTERM EXAM
1. Which of the following are risk factors for neuroleptic malignant
syndrome? Select all that applyAge
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2.Antipsychotic medications provide D2 blockade in the mesocortical
pathway causing which of thefollowing effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS)
Causes prolactinemia Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral
effects by blocking which of thefollowing receptors?
GABA
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
,type
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
,Serotonin
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
, Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific
signs and symptoms resultingfrom recent ingestion or exposure to a
substance is known as which of the following?
Substane
intoxicati
on
Substanc
e
withdraw
al
Substance use
disorderAny of the
above
Abnormal involuntary movements in a rhythmic pattern affecting face,
5.
mouth, tongue, jaw is knownas which of the following?
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
LATEST UPDATE|| NRNP 6675 MIDTERM EXAM
1. Which of the following are risk factors for neuroleptic malignant
syndrome? Select all that applyAge
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2.Antipsychotic medications provide D2 blockade in the mesocortical
pathway causing which of thefollowing effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS)
Causes prolactinemia Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral
effects by blocking which of thefollowing receptors?
GABA
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
,type
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
,Serotonin
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
, Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific
signs and symptoms resultingfrom recent ingestion or exposure to a
substance is known as which of the following?
Substane
intoxicati
on
Substanc
e
withdraw
al
Substance use
disorderAny of the
above
Abnormal involuntary movements in a rhythmic pattern affecting face,
5.
mouth, tongue, jaw is knownas which of the following?
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
